The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 01, 2026

Filed:

Sep. 06, 2022
Applicant:

Eisai R&d Management Co., Ltd., Tokyo, JP;

Inventors:

Toshiyuki Tamai, Tokyo, JP;

Satoshi Nagao, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/53 (2006.01); A61K 31/4184 (2006.01); A61K 31/439 (2006.01); A61P 1/08 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/53 (2013.01); A61K 31/4184 (2013.01); A61K 31/439 (2013.01); A61P 1/08 (2018.01); A61P 35/00 (2018.01);
Abstract

The present invention provides a pharmaceutical composition for treating a solid tumor, comprising (6S,9aS)—N-benzyl-8-({6-[3-(4-ethylpiperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-6-(2-fluoro-4-hydroxybenzyl)-4,7-dioxo-2-(prop-2-en-1-yl)hexahydro-2H-pyrazino[2,1-c][1,2,4]triazine-1(6H)-carboxamide (Compound A) represented by the formula (I) or a pharmaceutically acceptable salt thereof, wherein the pharmaceutical composition is administered to a human subject together with an effective amount of a 5-HTreceptor antagonist to suppress gastrointestinal symptoms in such a manner that Compound A or the pharmaceutically acceptable salt thereof is administered twice daily at a dose of about 10 mg to about 150 mg per dose of Compound A; and the gastrointestinal symptom is a gastrointestinal symptom associated with administration of Compound A or a pharmaceutically acceptable salt thereof


Find Patent Forward Citations

Quick Actions:

Tamai, Toshiyuki. (2026). Pharmaceutical composition for treating solid tumors (U.S. Patent No. 12721851). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12721851

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…